A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and ...

A new study shows that lowering protein intake could slow liver cancer in people with damaged livers. Researchers found that ...

A Rutgers-led study found that eating less protein may help slow liver cancer in people with impaired liver function. When ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income, according ...

Led by Zhongshan Hospital, affiliated with Fudan University, the trial involved 11 hospitals across China. Experts say the ...

“Large-scale efforts need to be made" in the fight against these cancers, said paper author Dr. Ju Dong Yang.

First-line nivolumab plus ipilimumab significantly improved survival versus lenvatinib or sorafenib in patients with unresectable liver cancer. The median overall survival of 23.7 months with the ...

A study presented at Digestive Disease Week 2016 found African American patients diagnosed with hepatocellular carcinoma had a 33 percent increased risk of death compared to non-Hispanic white ...

A woman with cancer that spread to her liver is getting a second chance at life after receiving an organ transplant from a living donor.

Stage 4 liver cancer, also known as metastatic liver cancer, is the most advanced stage of liver cancer where the cancer has ...